320-84-3 Usage
Uses
Used in Pharmaceutical Industry:
5-CHLORO-2-(TRIFLUOROMETHYL)BENZOYL CHLORIDE is used as a key intermediate in the synthesis of pharmaceuticals for its ability to contribute to the development of novel drug molecules. Its unique structure allows for the creation of compounds with specific therapeutic properties, enhancing the range of treatments available for various medical conditions.
Used in Agrochemical Industry:
In the agrochemical sector, 5-CHLORO-2-(TRIFLUOROMETHYL)BENZOYL CHLORIDE is utilized as a precursor in the production of agrochemicals, such as pesticides and herbicides. Its incorporation into these products can lead to improved efficacy and selectivity, contributing to more effective crop protection strategies.
Used in Dye Manufacturing:
5-CHLORO-2-(TRIFLUOROMETHYL)BENZOYL CHLORIDE is employed as a reactive component in the synthesis of dyes, where its specific chemical properties can be harnessed to produce a range of colorants with diverse applications, including textiles, plastics, and printing inks.
Used in Polymer Production:
5-CHLORO-2-(TRIFLUOROMETHYL)BENZOYL CHLORIDE also finds use in the polymer industry, where it can be incorporated into the synthesis of polymers with tailored properties. Its presence in the polymer backbone can influence characteristics such as stability, reactivity, and solubility, making it a valuable component in the development of new materials.
Used in Organic Chemistry:
5-CHLORO-2-(TRIFLUOROMETHYL)BENZOYL CHLORIDE is a versatile reagent in organic chemistry, where it can be used in various reactions to form a wide array of organic compounds. Its reactivity allows for the formation of new chemical bonds and the modification of existing ones, facilitating the synthesis of complex organic molecules for research and industrial applications.
Due to the reactivity of 5-CHLORO-2-(TRIFLUOROMETHYL)BENZOYL CHLORIDE, it is crucial to handle 5-CHLORO-2-(TRIFLUOROMETHYL)BENZOYL CHLORIDE with care, employing appropriate safety measures and protective equipment to minimize potential hazards during its use in various applications.
Check Digit Verification of cas no
The CAS Registry Mumber 320-84-3 includes 6 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 3 digits, 3,2 and 0 respectively; the second part has 2 digits, 8 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 320-84:
(5*3)+(4*2)+(3*0)+(2*8)+(1*4)=43
43 % 10 = 3
So 320-84-3 is a valid CAS Registry Number.
320-84-3Relevant academic research and scientific papers
FUSED MORPHOLINOPYRIMIDINES AND METHODS OF USE THEREOF
-
Paragraph 0534, (2015/08/03)
The present disclosure relates to Fused Morpholinopyrimidines, pharmaceutical compositions comprising an effective amount of a Fused Morpholinopyrimidine and methods for using a Fused Morpholinopyrimidine in the treatment of a neurodegenerative disease, comprising administering to a subject in need thereof an effective amount of a Fused Morpholinopyrimidine.
HERBICIDAL COMPOUNDS
-
Paragraph 0136, (2015/01/06)
The present invention relates to a method of controlling weeds at a locus, said method comprising application to the locus of a weed controlling amount of a herbicidal composition comprising a compound of Formula (I), or an agronomically acceptable salt o
Discovery of (R)-9-ethyl-1,3,4,10b-tetrahydro-7-trifluoromethylpyrazino[2, 1-a]isoindol-6(2H)-one, a selective, orally active agonist of the 5-HT 2C receptor
Wacker, Dean A.,Varnes, Jeffrey G.,Malmstrom, Sarah E.,Cao, Xueying,Hung, Chen-Pin,Ung, Thao,Wu, Ginger,Zhang, Ge,Zuvich, Eva,Thomas, Michael A.,Keim, William J.,Cullen, Mary Jane,Rohrbach, Kenneth W.,Qu, Qinling,Narayanan, Rangaraj,Rossi, Karen,Janovitz, Evan,Lehman-McKeeman, Lois,Malley, Mary F.,Devenny, James,Pelleymounter, Mary Ann,Miller, Keith J.,Robl, Jeffrey A.
, p. 1365 - 1379 (2007/10/03)
Robust pharmaceutical treatment of obesity has been limited by the undesirable side-effect profile of currently marketed therapies. This paper describes the synthesis and optimization of a new class of pyrazinoisoindolone- containing, selective 5-HT2C agonists as antiobesity agents. Key to optimization of the pyrazinoisoindolone core was the identification of the appropriate substitution pattern and functional groups which led to the discovery of (R)-9-ethyl-1,3,4,10b-tetrahydro-7-trifluoromethylpyrazino[2,1-a] isoindol-6(2H)-one (58), a 5-HT2C agonist with > 300-fold functional selectivity over 5-HT2B and > 70-fold functional selectivity over 5-HT2A. Oral dosing of 58 reduced food intake in an acute rat feeding model, which could be completely reversed by a selective 5-HT2C antagonist and caused a reduction in body weight gain in a 4-day rat model.
